Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Bader-Meunier

Showing results (111-120 of 231) with videos related to

Pageof 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory MyopathiesCyrielle Hou, Chloé Durrleman, Baptiste Periou, et al.
Haematologica|December 7, 2007
Rituximab therapy for childhood Evans syndromeBrigitte Bader-Meunier, Nathalie Aladjidi, Françoise Bellmann, et al.
Pediatric Radiology|February 6, 2013
MRI assessment of tenosynovitis in children with juvenile idiopathic arthritis: inter- and intra-observer variabilityKaren Lambot, Peter Boavida, Maria Beatrice Damasio, et al.
Journal of Nephrology|October 8, 2022
Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus CyclophosphamideMarwa Chbihi, Laurye-Anne Eveillard, Quentin Riller, et al.
Rheumatology (Oxford, England)|March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patientsHuong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
Arthritis Care & Research|December 20, 2016
Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in ChildhoodAshwaq AlE'ed, Patricia Vega-Fernandez, Eyal Muscal, et al.
Pediatric Research|June 11, 2026
Type I interferon signature does not correlate with disease activity in Blau syndromeBenjamin Fournier, Héloïse Reumaux, Isabelle Melki, et al.
The Journal of Allergy and Clinical Immunology|April 3, 2012
Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn diseaseCarl E I Janssen, Carlos D Rose, Gert De Hertogh, et al.
Rheumatology (Oxford, England)|March 14, 2015
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γKaren Put, Anneleen Avau, Ellen Brisse, et al.
Rheumatology (Oxford, England)|February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyTom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Pageof 24

Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory MyopathiesCyrielle Hou, Chloé Durrleman, Baptiste Periou, et al.
Haematologica|December 7, 2007
Rituximab therapy for childhood Evans syndromeBrigitte Bader-Meunier, Nathalie Aladjidi, Françoise Bellmann, et al.
Pediatric Radiology|February 6, 2013
MRI assessment of tenosynovitis in children with juvenile idiopathic arthritis: inter- and intra-observer variabilityKaren Lambot, Peter Boavida, Maria Beatrice Damasio, et al.
Journal of Nephrology|October 8, 2022
Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus CyclophosphamideMarwa Chbihi, Laurye-Anne Eveillard, Quentin Riller, et al.
Rheumatology (Oxford, England)|March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patientsHuong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
Arthritis Care & Research|December 20, 2016
Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in ChildhoodAshwaq AlE'ed, Patricia Vega-Fernandez, Eyal Muscal, et al.
Pediatric Research|June 11, 2026
Type I interferon signature does not correlate with disease activity in Blau syndromeBenjamin Fournier, Héloïse Reumaux, Isabelle Melki, et al.
The Journal of Allergy and Clinical Immunology|April 3, 2012
Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn diseaseCarl E I Janssen, Carlos D Rose, Gert De Hertogh, et al.
Rheumatology (Oxford, England)|March 14, 2015
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γKaren Put, Anneleen Avau, Ellen Brisse, et al.
Rheumatology (Oxford, England)|February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyTom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Pageof 24